                         SEQUENCE LISTING

<110>  Northeastern University
       Audax Medical, Inc.
 
<120>  Twin Base Linkers for Virus Inactivation

<130>  19815-0694

<150>  63/010,642
<151>  2020-04-15

<160>  296   

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  1

Lys Arg Ser Arg 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  2

Ser Ala Asp Glu 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  3

Asn Gly Thr Lys 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  4

Asn Phe Thr Ile 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  5

Asn Leu Thr Thr 
1               


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  6

Asn Thr Ser Asn 
1               


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  7

Ser Ala Ser Asp 
1               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  8

Ser Ala Ser Glu 
1               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  9

Ser Ala Cys Asp 
1               


<210>  10
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  10

Ser Ala Cys Glu 
1               


<210>  11
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  11

Ser Ala Pro Asp 
1               


<210>  12
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  12

Ser Ala Pro Glu 
1               


<210>  13
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  13

Ser Ala Asn Asp 
1               


<210>  14
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  14

Ser Ala Asn Glu 
1               


<210>  15
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  15

Ser Ala Gln Asp 
1               


<210>  16
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  16

Ser Ala Gln Glu 
1               


<210>  17
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  17

Ser Val Ser Asp 
1               


<210>  18
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  18

Ser Val Ser Glu 
1               


<210>  19
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  19

Ser Val Cys Asp 
1               


<210>  20
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  20

Ser Val Cys Glu 
1               


<210>  21
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  21

Ser Val Pro Asp 
1               


<210>  22
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  22

Ser Val Pro Glu 
1               


<210>  23
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  23

Ser Val Asn Asp 
1               


<210>  24
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  24

Ser Val Asn Glu 
1               


<210>  25
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  25

Ser Val Gln Asp 
1               


<210>  26
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  26

Ser Val Gln Glu 
1               


<210>  27
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  27

Ser Leu Ser Asp 
1               


<210>  28
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  28

Ser Leu Ser Glu 
1               


<210>  29
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  29

Ser Leu Cys Asp 
1               


<210>  30
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  30

Ser Leu Cys Glu 
1               


<210>  31
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  31

Ser Leu Pro Asp 
1               


<210>  32
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  32

Ser Leu Pro Glu 
1               


<210>  33
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  33

Ser Leu Asn Asp 
1               


<210>  34
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  34

Ser Leu Asn Glu 
1               


<210>  35
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  35

Ser Leu Gln Asp 
1               


<210>  36
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  36

Ser Leu Asp Glu 
1               


<210>  37
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  37

Ser Met Ser Glu 
1               


<210>  38
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  38

Ser Met Ser Asp 
1               


<210>  39
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  39

Ser Met Cys Glu 
1               


<210>  40
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  40

Ser Met Cys Asp 
1               


<210>  41
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  41

Ser Met Pro Asp 
1               


<210>  42
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  42

Ser Met Pro Glu 
1               


<210>  43
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  43

Ser Met Asn Asp 
1               


<210>  44
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  44

Ser Met Asn Glu 
1               


<210>  45
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  45

Ser Met Gln Asp 
1               


<210>  46
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  46

Ser Met Gln Glu 
1               


<210>  47
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  47

Pro Ala Ser Asp 
1               


<210>  48
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  48

Pro Ala Ser Glu 
1               


<210>  49
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  49

Pro Ala Cys Asp 
1               


<210>  50
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  50

Pro Ala Cys Glu 
1               


<210>  51
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  51

Pro Ala Pro Asp 
1               


<210>  52
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  52

Pro Ala Pro Glu 
1               


<210>  53
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  53

Pro Ala Asn Asp 
1               


<210>  54
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  54

Pro Ala Asn Glu 
1               


<210>  55
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  55

Pro Ala Gln Asp 
1               


<210>  56
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  56

Pro Ala Gln Glu 
1               


<210>  57
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  57

Pro Val Ser Asp 
1               


<210>  58
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  58

Pro Val Ser Glu 
1               


<210>  59
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  59

Pro Val Cys Asp 
1               


<210>  60
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  60

Pro Val Cys Glu 
1               


<210>  61
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  61

Pro Val Pro Asp 
1               


<210>  62
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  62

Pro Val Pro Glu 
1               


<210>  63
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  63

Pro Val Asn Asp 
1               


<210>  64
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  64

Pro Val Asn Glu 
1               


<210>  65
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  65

Pro Val Gln Asp 
1               


<210>  66
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  66

Pro Val Gln Glu 
1               


<210>  67
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  67

Pro Leu Ser Asp 
1               


<210>  68
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  68

Pro Leu Ser Glu 
1               


<210>  69
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  69

Pro Leu Cys Asp 
1               


<210>  70
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  70

Pro Leu Cys Glu 
1               


<210>  71
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  71

Pro Leu Pro Asp 
1               


<210>  72
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  72

Pro Leu Pro Glu 
1               


<210>  73
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  73

Pro Leu Asn Asp 
1               


<210>  74
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  74

Pro Leu Asn Glu 
1               


<210>  75
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  75

Pro Leu Gln Asp 
1               


<210>  76
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  76

Pro Leu Gln Glu 
1               


<210>  77
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  77

Pro Met Ser Asp 
1               


<210>  78
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  78

Pro Met Ser Glu 
1               


<210>  79
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  79

Pro Met Cys Asp 
1               


<210>  80
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  80

Pro Met Cys Glu 
1               


<210>  81
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  81

Cys Ala Ser Asp 
1               


<210>  82
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  82

Cys Ala Ser Glu 
1               


<210>  83
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  83

Cys Ala Cys Asp 
1               


<210>  84
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  84

Cys Ala Cys Glu 
1               


<210>  85
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  85

Cys Ala Pro Asp 
1               


<210>  86
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  86

Cys Ala Pro Glu 
1               


<210>  87
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  87

Cys Ala Asn Asp 
1               


<210>  88
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  88

Cys Ala Asn Glu 
1               


<210>  89
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  89

Cys Ala Gln Asp 
1               


<210>  90
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  90

Cys Ala Gln Glu 
1               


<210>  91
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  91

Cys Val Ser Asp 
1               


<210>  92
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  92

Cys Val Ser Glu 
1               


<210>  93
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  93

Cys Val Cys Asp 
1               


<210>  94
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  94

Cys Val Cys Glu 
1               


<210>  95
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  95

Cys Val Pro Asp 
1               


<210>  96
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  96

Cys Val Pro Glu 
1               


<210>  97
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  97

Cys Val Asn Asp 
1               


<210>  98
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  98

Cys Val Asn Glu 
1               


<210>  99
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  99

Cys Val Gln Asp 
1               


<210>  100
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  100

Cys Val Gln Glu 
1               


<210>  101
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  101

Cys Leu Ser Asp 
1               


<210>  102
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  102

Cys Leu Ser Glu 
1               


<210>  103
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  103

Cys Leu Cys Asp 
1               


<210>  104
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  104

Cys Leu Cys Glu 
1               


<210>  105
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  105

Cys Leu Pro Asp 
1               


<210>  106
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  106

Cys Leu Pro Glu 
1               


<210>  107
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  107

Cys Leu Asn Asp 
1               


<210>  108
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  108

Cys Leu Asn Glu 
1               


<210>  109
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  109

Cys Leu Gln Asp 
1               


<210>  110
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  110

Cys Leu Gln Glu 
1               


<210>  111
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  111

Cys Met Ser Asp 
1               


<210>  112
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  112

Cys Met Ser Glu 
1               


<210>  113
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  113

Cys Met Cys Asp 
1               


<210>  114
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  114

Cys Met Ser Glu 
1               


<210>  115
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  115

Cys Met Pro Asp 
1               


<210>  116
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  116

Cys Met Pro Glu 
1               


<210>  117
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  117

Cys Met Asn Asp 
1               


<210>  118
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  118

Cys Met Asn Glu 
1               


<210>  119
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  119

Cys Met Gln Asp 
1               


<210>  120
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  120

Cys Met Gln Glu 
1               


<210>  121
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  121

Thr Ala Ser Asp 
1               


<210>  122
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  122

Thr Ala Ser Glu 
1               


<210>  123
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  123

Thr Ala Cys Asp 
1               


<210>  124
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  124

Thr Ala Cys Glu 
1               


<210>  125
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  125

Thr Ala Pro Asp 
1               


<210>  126
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  126

Thr Ala Pro Glu 
1               


<210>  127
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  127

Thr Ala Asn Asp 
1               


<210>  128
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  128

Thr Ala Asn Glu 
1               


<210>  129
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  129

Thr Ala Gln Asp 
1               


<210>  130
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  130

Thr Ala Gln Glu 
1               


<210>  131
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  131

Thr Val Ser Asp 
1               


<210>  132
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  132

Thr Val Ser Glu 
1               


<210>  133
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  133

Thr Val Cys Asp 
1               


<210>  134
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  134

Thr Val Cys Glu 
1               


<210>  135
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  135

Thr Val Pro Asp 
1               


<210>  136
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  136

Thr Val Pro Glu 
1               


<210>  137
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  137

Thr Val Asn Asp 
1               


<210>  138
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  138

Thr Val Asn Glu 
1               


<210>  139
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  139

Thr Val Gln Asp 
1               


<210>  140
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  140

Thr Val Gln Glu 
1               


<210>  141
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  141

Thr Leu Ser Asp 
1               


<210>  142
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  142

Thr Leu Ser Glu 
1               


<210>  143
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  143

Thr Leu Cys Asp 
1               


<210>  144
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  144

Thr Leu Cys Glu 
1               


<210>  145
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  145

Thr Leu Pro Asp 
1               


<210>  146
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  146

Thr Leu Pro Glu 
1               


<210>  147
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  147

Thr Leu Asn Asp 
1               


<210>  148
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  148

Thr Leu Asn Glu 
1               


<210>  149
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  149

Thr Leu Gln Asp 
1               


<210>  150
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  150

Thr Leu Gln Glu 
1               


<210>  151
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  151

Thr Met Ser Asp 
1               


<210>  152
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  152

Thr Met Ser Glu 
1               


<210>  153
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  153

Thr Met Cys Asp 
1               


<210>  154
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  154

Thr Met Cys Glu 
1               


<210>  155
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  155

Thr Met Pro Asp 
1               


<210>  156
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  156

Thr Met Pro Glu 
1               


<210>  157
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  157

Thr Met Asn Asp 
1               


<210>  158
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  158

Thr Met Asn Glu 
1               


<210>  159
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  159

Thr Met Gln Asp 
1               


<210>  160
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  160

Thr Met Gln Glu 
1               


<210>  161
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  161

Gln Ala Ser Asp 
1               


<210>  162
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  162

Gln Ala Ser Glu 
1               


<210>  163
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  163

Gln Val Cys Asp 
1               


<210>  164
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  164

Gln Val Cys Glu 
1               


<210>  165
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  165

Gln Val Pro Asp 
1               


<210>  166
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  166

Gln Val Pro Glu 
1               


<210>  167
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  167

Gln Val Asn Asp 
1               


<210>  168
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  168

Gln Val Asn Glu 
1               


<210>  169
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  169

Gln Val Gln Asp 
1               


<210>  170
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  170

Gln Val Gln Glu 
1               


<210>  171
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  171

Gln Leu Ser Asp 
1               


<210>  172
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  172

Gln Leu Ser Glu 
1               


<210>  173
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  173

Gln Leu Cys Asp 
1               


<210>  174
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  174

Gln Leu Cys Glu 
1               


<210>  175
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  175

Gln Leu Pro Asp 
1               


<210>  176
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  176

Gln Leu Pro Glu 
1               


<210>  177
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  177

Gln Leu Asn Asp 
1               


<210>  178
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  178

Gln Leu Asn Glu 
1               


<210>  179
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  179

Gln Leu Gln Asp 
1               


<210>  180
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  180

Gln Leu Gln Glu 
1               


<210>  181
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  181

Gln Met Ser Asp 
1               


<210>  182
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  182

Gln Met Ser Glu 
1               


<210>  183
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  183

Gln Met Cys Asp 
1               


<210>  184
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  184

Gln Met Cys Glu 
1               


<210>  185
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  185

Gln Met Pro Asp 
1               


<210>  186
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  186

Gln Met Pro Glu 
1               


<210>  187
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  187

Gln Met Asn Asp 
1               


<210>  188
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  188

Gln Met Asn Glu 
1               


<210>  189
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  189

Gln Met Gln Asp 
1               


<210>  190
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  190

Gln Met Gln Glu 
1               


<210>  191
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  191

Met Ile His Ser 
1               


<210>  192
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  192

Ala Ile His Ser 
1               


<210>  193
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  193

Val Ile His Ser 
1               


<210>  194
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  194

Ile Ile His Ser 
1               


<210>  195
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  195

Leu Ile His Ser 
1               


<210>  196
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  196

Phe Ile His Ser 
1               


<210>  197
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  197

Tyr Ile His Ser 
1               


<210>  198
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  198

Trp Ile His Ser 
1               


<210>  199
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  199

Met Ala His Ser 
1               


<210>  200
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  200

Met Val His Ser 
1               


<210>  201
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  201

Met Leu His Ser 
1               


<210>  202
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  202

Met Met His Ser 
1               


<210>  203
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  203

Met Phe His Ser 
1               


<210>  204
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  204

Met Tyr His Ser 
1               


<210>  205
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  205

Met Trp His Ser 
1               


<210>  206
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  206

Ala Ile Arg Ser 
1               


<210>  207
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  207

Ala Ile Arg Lys 
1               


<210>  208
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  208

Ala Ile Asp Lys 
1               


<210>  209
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  209

Ala Ile Glu Lys 
1               


<210>  210
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  210

Met Ile His Thr 
1               


<210>  211
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  211

Met Ile His Asn 
1               


<210>  212
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  212

Met Ile His Gln 
1               


<210>  213
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  213

Ala Ser Cys Ser 
1               


<210>  214
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  214

Ala Thr Cys Ser 
1               


<210>  215
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  215

Ala Asn Cys Ser 
1               


<210>  216
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  216

Ala Gln Cys Ser 
1               


<210>  217
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  217

Ala Val Cys Ser 
1               


<210>  218
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  218

Val Ser Cys Ser 
1               


<210>  219
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  219

Val Thr Cys Ser 
1               


<210>  220
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  220

Val Asn Cys Ser 
1               


<210>  221
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  221

Val Gln Cys Ser 
1               


<210>  222
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  222

Val Val Cys Ser 
1               


<210>  223
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  223

Ile Ser Cys Ser 
1               


<210>  224
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  224

Ile Thr Cys Ser 
1               


<210>  225
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  225

Ile Asn Cys Ser 
1               


<210>  226
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  226

Ile Gln Cys Ser 
1               


<210>  227
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  227

Ile Val Cys Ser 
1               


<210>  228
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  228

Leu Ser Cys Ser 
1               


<210>  229
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  229

Leu Thr Cys Ser 
1               


<210>  230
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  230

Leu Asn Cys Ser 
1               


<210>  231
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  231

Leu Gln Cys Ser 
1               


<210>  232
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  232

Met Ser Cys Ser 
1               


<210>  233
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  233

Met Thr Cys Ser 
1               


<210>  234
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  234

Met Asn Cys Ser 
1               


<210>  235
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  235

Met Gln Cys Ser 
1               


<210>  236
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  236

Met Val Cys Ser 
1               


<210>  237
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  237

Phe Ser Cys Ser 
1               


<210>  238
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  238

Phe Thr Cys Ser 
1               


<210>  239
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  239

Phe Asn Cys Ser 
1               


<210>  240
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  240

Phe Gln Cys Ser 
1               


<210>  241
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  241

Phe Val Cys Ser 
1               


<210>  242
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  242

Tyr Ser Cys Ser 
1               


<210>  243
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  243

Tyr Thr Cys Ser 
1               


<210>  244
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  244

Tyr Asn Cys Ser 
1               


<210>  245
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  245

Tyr Gln Cys Ser 
1               


<210>  246
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  246

Tyr Val Cys Ser 
1               


<210>  247
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  247

Trp Ser Cys Ser 
1               


<210>  248
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  248

Trp Thr Cys Ser 
1               


<210>  249
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  249

Trp Asn Cys Ser 
1               


<210>  250
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  250

Trp Gln Cys Ser 
1               


<210>  251
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  251

Trp Val Cys Ser 
1               


<210>  252
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  252

Met Gly Ala Gln 
1               


<210>  253
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  253

Ala Gly Ala Gln 
1               


<210>  254
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  254

Val Gly Ala Gln 
1               


<210>  255
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  255

Ile Gly Ala Gln 
1               


<210>  256
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  256

Leu Gly Ala Gln 
1               


<210>  257
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  257

Phe Gly Ala Gln 
1               


<210>  258
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  258

Tyr Gly Ala Gln 
1               


<210>  259
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  259

Trp Gly Ala Gln 
1               


<210>  260
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  260

Ala Cys Ala Gln 
1               


<210>  261
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  261

Val Cys Ala Gln 
1               


<210>  262
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  262

Ile Cys Ala Gln 
1               


<210>  263
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  263

Leu Cys Ala Gln 
1               


<210>  264
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  264

Met Cys Ala Gln 
1               


<210>  265
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  265

Phe Cys Ala Gln 
1               


<210>  266
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  266

Tyr Cys Ala Gln 
1               


<210>  267
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  267

Trp Cys Ala Gln 
1               


<210>  268
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  268

Ala Pro Ala Gln 
1               


<210>  269
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  269

Val Pro Ala Gln 
1               


<210>  270
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  270

Ile Pro Ala Gln 
1               


<210>  271
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  271

Leu Pro Ala Gln 
1               


<210>  272
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  272

Phe Pro Ala Gln 
1               


<210>  273
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  273

Tyr Pro Ala Gln 
1               


<210>  274
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  274

Trp Pro Ala Gln 
1               


<210>  275
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  275

Ala Gly Val Gln 
1               


<210>  276
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  276

Val Gly Val Gln 
1               


<210>  277
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  277

Ile Gly Val Gln 
1               


<210>  278
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  278

Leu Gly Val Gln 
1               


<210>  279
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  279

Phe Gly Val Gln 
1               


<210>  280
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  280

Tyr Gly Val Gln 
1               


<210>  281
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  281

Trp Gly Val Gln 
1               


<210>  282
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  282

Ala Cys Val Gln 
1               


<210>  283
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  283

Val Cys Val Gln 
1               


<210>  284
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  284

Ile Cys Val Gln 
1               


<210>  285
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  285

Leu Cys Val Gln 
1               


<210>  286
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  286

Met Cys Val Gln 
1               


<210>  287
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  287

Phe Cys Val Gln 
1               


<210>  288
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  288

Tyr Cys Val Gln 
1               


<210>  289
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  289

Trp Cys Val Gln 
1               


<210>  290
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  290

Ala Pro Val Gln 
1               


<210>  291
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  291

Val Pro Val Gln 
1               


<210>  292
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  292

Ile Pro Val Gln 
1               


<210>  293
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  293

Leu Pro Val Gln 
1               


<210>  294
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  294

Phe Pro Val Gln 
1               


<210>  295
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  295

Tyr Pro Val Gln 
1               


<210>  296
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Targeting moiety

<400>  296

Trp Pro Val Gln 
1               


